Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY: LH )

229.95 +1.12 (+0.49%)
Streaming Delayed Price Updated: 10:25 AM EDT, Aug 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Laboratory Corp American Holdings

< Previous 1 2 3 4 5 Next >
Analyst Expectations For Labcorp Holdings's Future
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H.... 
Via Benzinga
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Via Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024... 
Via Benzinga
Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Labcorp Holdings
Via Benzinga
Analyst Ratings For Laboratory Corp
Via Benzinga
Laboratory Corp's Ex-Dividend Date Is Monday, Here's What You Need To Know
Via Benzinga
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions. 
Via Talk Markets
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's... 
Via Benzinga
LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024
LH stock results show that Laboratory Corp beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate about $100 million in annual revenue, with the transaction valued at $237.5... 
Via Benzinga
Earnings Scheduled For February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the latest advancements in Alzheimer's detection. 
Via Benzinga
7 Analysts Have This to Say About Laboratory Corp
Via Benzinga
Why Fortrea Holdings Shares Are Gaining Today
Activist hedge fund Starboard Value holds a  
Via Benzinga
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. 
Via Talk Markets
SLB, Marvell Technology And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today
The company's first quarter as a separate entity was better than anticipated. 
Via The Motley Fool
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are... 
Via Benzinga
Bear Of The Day: Labcorp
Analysts have slashed their earnings expectations for the company, pushing it down to a Zacks Rank #5 (Strong Sell). 
Via Talk Markets
Expert Ratings for Laboratory Corp
Via Benzinga
Where Laboratory Corp Stands With Analysts
Via Benzinga
Expert Ratings for Laboratory Corp
Via Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
The 7 Most Undervalued Value Stocks to Buy Now: August 2023
While it’s difficult to ignore the hot flavors of the week, investors should target these undervalued value stocks for the best bargains. 
Via InvestorPlace
Visualizing The Entire S&P 500
One of the biggest challenges market analysts have is how to visualize the companies that make up the S&P 500. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.